Correlation Between Mesopic Retinal Sensitivity and Optical Coherence Tomographic Metrics of the Outer Retina in Patients With Non-Atrophic Dry Age-Related Macular Degeneration.
Age-Related Macular Degeneration.
Thomas CJ, Mirza RG, Gill MK.
Med Clin North Am. 2021 May;105(3):473-491. doi: 10.1016/j.mcna.2021.01.003. Epub 2021 Apr 2.
Treatment of dry age-related macular degeneration: A review.
Girgis S, Lee LR.
Clin Exp Ophthalmol. 2023 Nov;51(8):835-852. doi: 10.1111/ceo.14294. Epub 2023 Sep 22.
LIGHTSITE III: 13-Month Efficacy and Safety Evaluation of Multiwavelength Photobiomodulation in Nonexudative (Dry) Age-Related Macular Degeneration Using the Lumithera Valeda Light Delivery System.
Boyer D, Hu A, Warrow D, Xavier S, Gonzalez V, Lad E, Rosen RB, Do D, Schneiderman T, Ho A, Munk MR, Jaffe G, Tedford SE, Croissant CL, Walker M, Rückert R, Tedford CE.
Retina. 2024 Mar 1;44(3):487-497. doi: 10.1097/IAE.0000000000003980.
Treatments for dry age-related macular degeneration: therapeutic avenues, clinical trials and future directions.
Cabral de Guimaraes TA, Daich Varela M, Georgiou M, Michaelides M.
Br J Ophthalmol. 2022 Mar;106(3):297-304. doi: 10.1136/bjophthalmol-2020-318452. Epub 2021 Mar 19.
Age-related macular degeneration.
Lim LS, Mitchell P, Seddon JM, Holz FG, Wong TY.
Lancet. 2012 May 5;379(9827):1728-38. doi: 10.1016/S0140-6736(12)60282-7.
Treatment for dry age-related macular degeneration: where we stand in 2024.
Wheeler S, Mahmoudzadeh R, Randolph J.
Curr Opin Ophthalmol. 2024 Sep 1;35(5):359-364. doi: 10.1097/ICU.0000000000001064. Epub 2024 Jun 13.
Recent Advances in Age-Related Macular Degeneration Therapies.
Fabre M, Mateo L, Lamaa D, Baillif S, Pagès G, Demange L, Ronco C, Benhida R.
Molecules. 2022 Aug 10;27(16):5089. doi: 10.3390/molecules27165089.
Mechanisms of age-related macular degeneration and therapeutic opportunities.
van Lookeren Campagne M, LeCouter J, Yaspan BL, Ye W.
J Pathol. 2014 Jan;232(2):151-64. doi: 10.1002/path.4266.
C5 Inhibitor Avacincaptad Pegol for Geographic Atrophy Due to Age-Related Macular Degeneration: A Randomized Pivotal Phase 2/3 Trial.
Jaffe GJ, Westby K, Csaky KG, Monés J, Pearlman JA, Patel SS, Joondeph BC, Randolph J, Masonson H, Rezaei KA.
Ophthalmology. 2021 Apr;128(4):576-586. doi: 10.1016/j.ophtha.2020.08.027. Epub 2020 Sep 1.
Age-related macular degeneration (AMD): pathogenesis and therapy.
Nowak JZ.
Pharmacol Rep. 2006 May-Jun;58(3):353-63.
